EA201401074A1 - Фармацевтические составы, содержащие хондроитинсульфат и производные гиалуроновой кислоты - Google Patents
Фармацевтические составы, содержащие хондроитинсульфат и производные гиалуроновой кислотыInfo
- Publication number
- EA201401074A1 EA201401074A1 EA201401074A EA201401074A EA201401074A1 EA 201401074 A1 EA201401074 A1 EA 201401074A1 EA 201401074 A EA201401074 A EA 201401074A EA 201401074 A EA201401074 A EA 201401074A EA 201401074 A1 EA201401074 A1 EA 201401074A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- hyaluronic acid
- pharmaceutical compositions
- compositions containing
- chondroitinsulphate
- acid derivatives
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
- A61K31/728—Hyaluronic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
- C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
- C08B37/0069—Chondroitin-4-sulfate, i.e. chondroitin sulfate A; Dermatan sulfate, i.e. chondroitin sulfate B or beta-heparin; Chondroitin-6-sulfate, i.e. chondroitin sulfate C; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
- C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
- C08B37/0072—Hyaluronic acid, i.e. HA or hyaluronan; Derivatives thereof, e.g. crosslinked hyaluronic acid (hylan) or hyaluronates
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biochemistry (AREA)
- Materials Engineering (AREA)
- Polymers & Plastics (AREA)
- Urology & Nephrology (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Inorganic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Изобретение относится к фармацевтическим составам, содержащим комбинацию заданных производных гиалуроновой кислоты с высокой молекулярной массой и хондроитинсульфата и использующимся для лечения остеоартрита, субхондральных поражений, остеопороза, синовита, теносиновита, тендинита, тендиноза, а также в качестве внутрисуставной промывочной жидкости и вязкого заменителя синовиальной жидкости после хирургического лечения остеохондральных поражений. Данные составы также применимы для лечения интерстициального цистита.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT000098A ITPD20120098A1 (it) | 2012-03-30 | 2012-03-30 | "nuove formulazioni faramaceutiche contenenti condroitin solfato e derivati dell'acido ialuronico" |
PCT/IB2013/052443 WO2013144867A1 (en) | 2012-03-30 | 2013-03-27 | Pharmaceutical formulations comprising chondroitin sulfate and hyaluronic acid derivatives |
Publications (2)
Publication Number | Publication Date |
---|---|
EA201401074A1 true EA201401074A1 (ru) | 2015-01-30 |
EA029237B1 EA029237B1 (ru) | 2018-02-28 |
Family
ID=46000143
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA201792023A EA201792023A3 (ru) | 2012-03-30 | 2013-03-27 | Фармацевтические составы, содержащие хондроитин сульфат и производные гиалуроновой кислоты |
EA201401074A EA029237B1 (ru) | 2012-03-30 | 2013-03-27 | Вязкие смазки, содержащие хондроитин сульфат и производные гиалуроновой кислоты |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA201792023A EA201792023A3 (ru) | 2012-03-30 | 2013-03-27 | Фармацевтические составы, содержащие хондроитин сульфат и производные гиалуроновой кислоты |
Country Status (12)
Country | Link |
---|---|
US (2) | US9655918B2 (ru) |
EP (3) | EP3449927B1 (ru) |
CN (1) | CN104220078A (ru) |
CA (1) | CA2868078C (ru) |
EA (2) | EA201792023A3 (ru) |
ES (2) | ES2709799T3 (ru) |
HR (1) | HRP20190131T1 (ru) |
IT (1) | ITPD20120098A1 (ru) |
PL (1) | PL2946782T3 (ru) |
SI (1) | SI2946782T1 (ru) |
TR (1) | TR201901472T4 (ru) |
WO (1) | WO2013144867A1 (ru) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ITPD20120098A1 (it) * | 2012-03-30 | 2013-10-01 | Fidia Farmaceutici | "nuove formulazioni faramaceutiche contenenti condroitin solfato e derivati dell'acido ialuronico" |
ITMI20132116A1 (it) * | 2013-12-18 | 2015-06-19 | Apharm Srl | Associazione di glicosamminoglicani e ciclodestrine |
CN104940221A (zh) * | 2015-05-13 | 2015-09-30 | 北京大清生物技术有限公司 | 一种用于膀胱和尿道上皮损伤修复的组合物 |
EP3111941A1 (en) | 2015-06-30 | 2017-01-04 | Süleyman Patir | Compositions comprising chondroitin sulfate for prophylaxis or treatment of damaged articular cartilage |
ES2769059T3 (es) * | 2017-05-12 | 2020-06-24 | Farco Gmbh | Composición de instilación de la vejiga que contiene sulfato de condonitina (20 mg/ml), ácido hialurónico (16 mg/ml) y buffer de fosfato (pH 6,1 a 7,9) con mayor estabilidad de almacenamiento para el tratamiento de la cistitis |
EP3400951B1 (de) * | 2017-05-12 | 2019-12-11 | Farco-Pharma GmbH | Blaseninstillationszusammensetzung enthaltend chondoitinsulfat (4,5 mg/ml), hyaluronsäure (16 mg/ml) und phosphatpuffer (ph 6,1 bis 7,9) mit erhöhter lagerstabiliät zur behandlung von cystitis |
WO2019060696A1 (en) | 2017-09-25 | 2019-03-28 | Surface Pharmaceuticals, Inc. | OPTHALMIC PHARMACEUTICAL COMPOSITIONS AND METHODS FOR THE TREATMENT OF OCULAR SURFACE DISEASE |
CN113366025A (zh) * | 2019-01-30 | 2021-09-07 | 鲍希与洛姆伯股份有限公司 | 交联的聚合物网络及其用途 |
IT201900024208A1 (it) * | 2019-12-17 | 2021-06-17 | Altergon Sa | Miscele iniettabili di acido ialuronico per uso in dermoestetica |
TR201922945A2 (tr) * | 2019-12-31 | 2021-07-26 | Vsy Biyoteknoloji Ve Ilac Sanayi Anonim Sirketi | Osteoartri̇t tedavi̇si̇ i̇çi̇n propoli̇s i̇çeri̇kli̇ yeni̇ bi̇r vi̇skoelasti̇k formülasyonu ve bunun üreti̇m yöntemi̇ |
CN111333879B (zh) * | 2020-04-16 | 2022-08-16 | 山东众山生物科技有限公司 | 一种交联透明质酸的硫酸软骨素类化合物及其应用 |
Family Cites Families (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1212892B (it) | 1983-10-11 | 1989-11-30 | Della Valle Francesco | Acido ialuronico ottenuto per mezzodi filtrazione molecolare sprovvisto di attivita' infiammatoria e sua utilizzazione terapeutica |
DK171029B1 (da) | 1983-10-11 | 1996-04-22 | Fidia Spa | Hyaluronsyrefraktion, fremgangsmåde til fremstilling deraf samt ophthalmiske præparater indeholdende hyaluronsyrefraktion |
US4713448A (en) | 1985-03-12 | 1987-12-15 | Biomatrix, Inc. | Chemically modified hyaluronic acid preparation and method of recovery thereof from animal tissues |
US6051560A (en) | 1986-06-26 | 2000-04-18 | Nestle S.A. | Chrondroitin sulfate/sodium hyaluronate composition |
IT1219587B (it) | 1988-05-13 | 1990-05-18 | Fidia Farmaceutici | Polisaccaridi carbossiilici autoreticolati |
IT1263393B (it) | 1993-07-30 | 1996-08-05 | Fidia Advanced Biopolymers Srl | Processo per la preparazione e purificazione di acido ialuronico ad alto peso molecolare |
ITPD940054A1 (it) | 1994-03-23 | 1995-09-23 | Fidia Advanced Biopolymers Srl | Polisaccaridi solfatati |
IT1291291B1 (it) * | 1997-04-30 | 1999-01-07 | Chemedica Sa | Uso di acido ialuronico e relativi sali per la preparazione di una soluzione acquosa utile come liquido di lavaggio intra-articolare |
US6872819B1 (en) * | 1998-05-27 | 2005-03-29 | Fidia Advanced Biopolymers S.R.L. | Biomaterials containing hyaluronic acid derivatives in the form of three-dimensional structures free from cellular components or products thereof for the in vivo regeneration of tissue cells |
ITPD980169A1 (it) * | 1998-07-06 | 2000-01-06 | Fidia Advanced Biopolymers Srl | Ammidi dell'acido ialuronico e dei suoi derivati e processo per la loro preparazione. |
DE10053053A1 (de) * | 2000-10-19 | 2002-05-16 | Knoell Hans Forschung Ev | Pharmazeutische Formulierungen zur Hemmung von entzündlichen Arthritiden |
MXPA01011542A (es) | 2001-11-13 | 2003-05-22 | Alcon Inc | Regeneracion del cartilago articular da°ado por la osteoartritis de grado i y ii, mediante la aplicacion intra-articular de una mezcla de hialuronato de sodio y de condroitin sulfato en un vehiculo de gel. |
GB0130603D0 (en) * | 2001-12-20 | 2002-02-06 | Renaissance Healthcare Europ L | Improvements in or relating to ophthalmic solutions |
WO2004034980A2 (en) * | 2002-10-16 | 2004-04-29 | Marcum Frank D | Treatment for traumatic synovitis and damaged articular cartilage |
US7504387B2 (en) * | 2002-10-16 | 2009-03-17 | Arthrodynamic Technologies, Animal Health Division, Inc. | Glycosaminoglycan composition and method for treatment and prevention of interstitial cystitis |
ITPD20050056A1 (it) * | 2005-03-02 | 2006-09-03 | Fidia Farmaceutici | Derivati ammidici del'acido ialuronico in osteoartrosi |
ITMI20061030A1 (it) * | 2006-05-26 | 2007-11-27 | Altergon Sa | Nuova composizione comprendente glicosamminoglicani a viscosita' controllata e uso di tale composizione nella terapuia della cistite cronica |
ITPD20060219A1 (it) * | 2006-05-31 | 2007-12-01 | Fidia Farmaceutici | Composizioni farmaceutiche contenenti acido ialuronico solfatato nel trattamento dell'osteoartrosi |
CN100594029C (zh) * | 2006-07-24 | 2010-03-17 | 凌沛学 | 一种关节腔内注射用药物组合物 |
US8343942B2 (en) * | 2008-04-04 | 2013-01-01 | University Of Utah Research Foundation | Methods for treating interstitial cystitis |
IT1393945B1 (it) * | 2009-04-21 | 2012-05-17 | Fidia Farmaceutici | Composizioni comprendenti acido ialuronico, acido ialuronico solfatato, calcio e vitamina d3 nel trattamento delle malattie osteoarticolari e muscoloscheletriche |
IT1395392B1 (it) | 2009-08-27 | 2012-09-14 | Fidia Farmaceutici | Geli viscoelastici come nuovi filler |
FR2954165B1 (fr) * | 2009-12-18 | 2012-01-13 | Jean-Noel Thorel | Compositions injectables a usage intra-articulaire associant un agent de viscosupplementation et un milieu de croissance des fibroblastes |
ITPD20120098A1 (it) * | 2012-03-30 | 2013-10-01 | Fidia Farmaceutici | "nuove formulazioni faramaceutiche contenenti condroitin solfato e derivati dell'acido ialuronico" |
-
2012
- 2012-03-30 IT IT000098A patent/ITPD20120098A1/it unknown
-
2013
- 2013-03-27 EA EA201792023A patent/EA201792023A3/ru unknown
- 2013-03-27 SI SI201331339T patent/SI2946782T1/sl unknown
- 2013-03-27 TR TR2019/01472T patent/TR201901472T4/tr unknown
- 2013-03-27 CA CA2868078A patent/CA2868078C/en active Active
- 2013-03-27 ES ES15171519T patent/ES2709799T3/es active Active
- 2013-03-27 US US14/389,301 patent/US9655918B2/en active Active
- 2013-03-27 EP EP18200663.5A patent/EP3449927B1/en active Active
- 2013-03-27 EP EP15171519.0A patent/EP2946782B1/en active Active
- 2013-03-27 WO PCT/IB2013/052443 patent/WO2013144867A1/en active Application Filing
- 2013-03-27 CN CN201380018447.5A patent/CN104220078A/zh active Pending
- 2013-03-27 ES ES18200663T patent/ES2887581T3/es active Active
- 2013-03-27 EP EP13722549.6A patent/EP2830636A1/en not_active Withdrawn
- 2013-03-27 PL PL15171519T patent/PL2946782T3/pl unknown
- 2013-03-27 EA EA201401074A patent/EA029237B1/ru not_active IP Right Cessation
-
2017
- 2017-04-17 US US15/489,299 patent/US10821131B2/en active Active
-
2019
- 2019-01-21 HR HRP20190131TT patent/HRP20190131T1/hr unknown
Also Published As
Publication number | Publication date |
---|---|
ITPD20120098A1 (it) | 2013-10-01 |
SI2946782T1 (sl) | 2019-03-29 |
US20170216344A1 (en) | 2017-08-03 |
US10821131B2 (en) | 2020-11-03 |
EA029237B1 (ru) | 2018-02-28 |
EA201792023A3 (ru) | 2018-04-30 |
EP2946782A2 (en) | 2015-11-25 |
ES2887581T3 (es) | 2021-12-23 |
PL2946782T3 (pl) | 2019-04-30 |
EP2946782B1 (en) | 2018-11-07 |
WO2013144867A1 (en) | 2013-10-03 |
CA2868078A1 (en) | 2013-10-03 |
EP2830636A1 (en) | 2015-02-04 |
EP2946782A3 (en) | 2016-02-24 |
CA2868078C (en) | 2020-04-14 |
EP3449927B1 (en) | 2021-06-23 |
ES2709799T3 (es) | 2019-04-17 |
EA201792023A2 (ru) | 2018-01-31 |
EP3449927A1 (en) | 2019-03-06 |
TR201901472T4 (tr) | 2019-02-21 |
US20150072954A1 (en) | 2015-03-12 |
HRP20190131T1 (hr) | 2019-03-22 |
US9655918B2 (en) | 2017-05-23 |
CN104220078A (zh) | 2014-12-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA201401074A1 (ru) | Фармацевтические составы, содержащие хондроитинсульфат и производные гиалуроновой кислоты | |
ECSP17039547A (es) | Nuevas normalizaciones y dispositivos médicos para la preparación de plasma rico en plaquetas (prp) o concentrado de médula ósea (bmc) solos o combinados con ácido hialurónico | |
BR112012017488A2 (pt) | "dispositivo" | |
BR112014032990A2 (pt) | seringa | |
CL2014003388A1 (es) | Compuestos derivados de triazolona, como inhibidores de mpges-1; proceso de preparacion de dichos compuestos; composicion farmaceutica que los comprende, util para el tratamiento de inflamacion, asma, epoc, artritis, enfermedad de parkinson y enfermedades autoinmunes, entre otras enfermedades. | |
NI201400150A (es) | Nuevos derivados tienopirimidina, un proceso para su preparación y composiciones farmacéuticas que los contienen. | |
BR112015018838A2 (pt) | estabilidade melhorada de novas composições líquidas | |
CY1120204T1 (el) | Αμορφη στερεα διασπορα για χρηση σε θεραπεια καρκινου του εγκεφαλο | |
EA201400771A1 (ru) | Новые производные азетидина, фармацевтические композиции и их применение | |
BR112013005764A2 (pt) | malha cirúrgica | |
BR112013032619A2 (pt) | métodos e composições relacionados com reciclagem dos resíduos de polímero | |
CZ308492B6 (cs) | Kosmetická kompozice na bázi kyseliny hyaluronové, způsob její přípravy a použití | |
MX2016002794A (es) | Compuestos antiproliferativos. | |
CL2012003287A1 (es) | Complejo obtenido a partir de la mezcla de sulfato de condroitina, o una de sus sales, y acido hialuronico, o una de sus sales, con alto peso molecular; composicion farmaceutica que lo comprende; composicion cosmetica; procedimiento para su preparacion, util en enfermedades de las articulaciones, los tendones y del tejido conjuntivo. | |
MX342131B (es) | Eliminacion selectiva de celulas erosivas. | |
EA201501030A1 (ru) | Новые отвердители и разлагаемые полимеры и композиты на их основе | |
CY1121238T1 (el) | Παραγωγα παντοθενικου για την αντιμετωπιση νευρολογικων διαταραχων | |
BR112016018177A2 (pt) | Novos éteres de celulose esterificados de alto peso molecular e homogeneidade | |
RU2014108821A (ru) | Устойчивый к расщеплению сшитый низкомолекулярный гиалуронат | |
ECSP14013157A (es) | Formulaciones liofilizadas de fgf-18 | |
MX2014008373A (es) | Conjugados antagonistas de integrina para suministro dirigido a celulas que expresan alfa-v-beta-3. | |
BR112015004979A2 (pt) | processo para melhorar as propriedades reológicas de uma dispersão aquosa | |
EA201590708A1 (ru) | Модифицированные производные гиалуроновой кислоты и их применение | |
MX2016010872A (es) | Regimen de dosificacion del compuesto de factor de crecimiento de fibroblastos 18. | |
MX2012006265A (es) | Formulaciones disacaridas hipersulfatadas. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s) |
Designated state(s): AZ KG TJ TM |